Affordable and Safe Prescription Drug Importation Act
- Last Action
- 3/3/2017
Actions
- 2017-03-03Referred to the Subcommittee on Health.
- 2017-02-28Referred to the House Committee on Energy and Commerce.
- 2017-02-28Introduced in House
- 2017-02-28Introduced in House
CRS Summary
As of 2017-02-28 (00)
Affordable and Safe Prescription Drug Importation Act
This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. The FDA, within two years, may permit the importation of prescription drugs from other countries.
The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.
Cosponsors (20)
- LLOYD DOGGETT (D-TX)
- Gwen Moore (D-WI)
- ROBERT BRADY (D-PA)
- Ro Khanna (D-CA)
- Steve Cohen (D-TN)
- ROSA DELAURO (D-CT)
- Pramila Jayapal (D-WA)
- BARBARA LEE (D-CA)
- MARCY KAPTUR (D-OH)
- JANICE SCHAKOWSKY (D-IL)
- ELEANOR NORTON (D-DC)
- Chellie Pingree (D-ME)
- Peter Welch (D-VT)
- EARL BLUMENAUER (D-OR)
- Mark Pocan (D-WI)
- JAMES LANGEVIN (D-RI)
- BRAD SHERMAN (D-CA)
- Keith Ellison (D-MN)
- Beto O'Rourke (D-TX)
- Tulsi Gabbard (D-HI)
Subjects
- Administrative law and regulatory procedures
- Canada
- Congressional oversight
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Government information and archives
- Government studies and investigations
- Prescription drugs
- Trade restrictions
- User charges and fees
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.